| Literature DB >> 30967952 |
Nabil A Al-Zoubi1, Nawaf J Shatnawi1.
Abstract
PURPOSE: Little is known about the existence of potential gender disparities in peripheral arterial occlusive disease. To our knowledge, this is the first study to analyze differences attributed to gender in type-2 diabetic patients with symptomatic peripheral arterial occlusive disease, with regard to clinical presentations, risk factors and anatomical distributions of atherosclerosis. PATIENTS AND METHODS: This study was conducted at King Abdullah University Hospital, Jordan. Medical records of all diabetic (type-2) patients who presented with symptomatic peripheral arterial occlusive disease in the period from January 2012 and November 2017 were reviewed, data were collected retrospectively. In all, 364 patients (282 males and 82 females) were involved. Criteria for diagnosis include the following Ankle-Brachial Index ⩽ 0.9 and intermittent claudication or critical limb ischemia. Risk factors for atherosclerosis (age, smoking and hypertension) and computed tomography-angiogram findings were analyzed using Statistical Package for the Social Sciences. p < 0.05 was considered statistically significant.Entities:
Keywords: Gender differences; PAOD; critical limb ischemia; intermittent claudication; type-2 diabetes mellitus
Year: 2019 PMID: 30967952 PMCID: PMC6444770 DOI: 10.1177/2050312119840198
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Mean values of continuous variables.
| Mean value of continuous risk variable (SD) | Gender | p-value | |
|---|---|---|---|
| Male | female | ||
| Mean age (SD) | 62.61 (10.54) | 67.61 (10.62) | 0.000* |
| HbA1c (SD) | 8.51 (2.06) | 9.07 (2.03) | 0.03* |
| Total cholesterol (SD) | 4.66 (1.13) | 4.72 (1.15) | 0.674 |
| Triglyceride (SD) | 2.35 (1.49) | 2.25 (1.03) | 0.592 |
| LDL (SD) | 3.01 (0.87) | 3.06 (1.04) | 0.713 |
| HDL (SD) | 0.935 (0.24) | 1.02 (0.31) | 0.009* |
| CRP (SD) | 60.40 (60.39) | 63.47 (41.39) | 0.666 |
| MPV (SD) | 9.70 (1.22) | 9.82 (1.12) | 0.418 |
HbA1c: hemoglobin A1c; CRP: C-reactive protein; MPV: mean platelet volume; SD: standard deviation; LDL: low-density lipoprotein; HDL: high-density lipoprotein.
Categorical risk factors in relation to gender.
| Categorical CV risk variable | Gender | Total N | p-value | OR (95% CI) | |
|---|---|---|---|---|---|
| Male, n | Female, n | ||||
| Age ⩽ 60 years | 145 | 26 | 171 | 0.002 | 2.28 (1.36–3.84) |
| HbA1c ⩽ 7.5% | 116 | 21 | 137 | 0.014 | 2.03 (1.17–3.52) |
| Intermittent claudication | 107 | 19 | 126 | 0.017 | 2.03 (1.15–3.57) |
| Unilateral symptoms | 228 | 72 | 300 | 0.187 | 0.57 (0.28–1.21) |
| Arterial hypertension: no | 110 | 31 | 141 | 0.898 | 1.05 (0.63–1.75) |
| Cardiac disease: no | 172 | 55 | 227 | 0.365 | 0.77 (0.46–1.3) |
| Smoking: no | 109 | 28 | 137 | 0.518 | 1.22 (0.73–2.04) |
CV: cardiovascular; HbA1c: hemoglobin A1c.
Arterial and segmental HRAL in relation to gender.
| Segmental and arterial HRAL | Gender | Total N | p-value | OR (95% CI) | |
|---|---|---|---|---|---|
| Male | Female | ||||
| Aorto-iliac HRAL: no | 170 | 57 | 227 | 0.154 | 0.67 (0.4–1.13) |
| Femoro-popliteal HRLA: no | 115 | 26 | 141 | 0.157 | 1.48 (0.88–2.5) |
| Crural HRAL: no | 122 | 33 | 155 | 0.704 | 1.13 (0.69–1.87) |
| Aortic HRAL: no | 245 | 69 | 314 | 0.585 | 1.25 (0.63–2.48) |
| Common IA HRAL: no | 208 | 73 | 281 | 0.003 | 0.35 (0.17–0.73) |
| External IA HRAL: No | 234 | 67 | 301 | 0.868 | 1.09 (0.58–2.07) |
| Common FA HRAL: No | 254 | 72 | 326 | 0.542 | 1.26 (0.59–2.72) |
| Superficial FA HRAL: No | 163 | 36 | 199 | 0.032 | 1.75 (1.07–2.87) |
| Deep F.A HRAL: No | 267 | 70 | 337 | 0.008 | 3.05 (1.37–6.81) |
| Popliteal A HRAL: No | 211 | 57 | 268 | 0.393 | 1.30 (0.76–2.24) |
| Anterior TA HRAL: No | 156 | 47 | 203 | 0.801 | 0.92 (0.56–1.52) |
| Posterior TA HRAL: No | 168 | 39 | 207 | 0.058 | 1.63 (0.99–2.66) |
| Peroneal A HRAL: no | 204 | 49 | 253 | 0.04 | 1.76 (1.06–2.94) |
HRAL: hemodynamic relevant arterial lesion; IA: internal iliac; FA: femoral artery; TA: tibial artery; A: artery; N: number.